|
|
 |
| |
01 Facts & Files
02 Quality Assurance
03 Locations
04 Strategical Partner
|
|
| |
Gerresheimer Group acquires European market leader for medical plastic systems
|
|
With the Wilden Group Gerresheimer is also market leader for plastic systems
A key chapter is added to the growth story of the Gerresheimer Group. In the German company Wilden AG, Gerresheimer acquires the European market leader for pharmaceutical drug-delivery systems based on plastic. “This marks a giant step in our strategy to generate sustained growth through the acquisition of technology and market leaders in the field of pharma packaging and systems. Through the purchase which brings around €240m of additional annual sales, Gerresheimer grows into a new order of magnitude“, says Gerresheimer CEO Dr. Axel Herberg.
In Wilden, Gerresheimer acquires the market and technology leader for innovative plastic systems. The business comprises the divisions of “Medical Plastic Systems” (pharmaceutics, diagnostics, medical technology and consumer healthcare) and “Technical Plastic Systems”. The product segment of Medical Plastic Systems accounts for two thirds of the total sales of €240m. The Technical Plastic Systems Division manufactures sophisticated injection-moulded products mainly for the automobile industry.
“Through the takeover of Wilden we have acquired the market, quality and technology leader in all its product segments, which are characterised by highly dynamic growth,” Herberg comments on the acquisition, adding with regard to the Gerresheimer Group: “This is a quantum leap for us. Our pharma business in plastic thereby grows into a new order of magnitude which gives us a completely new positioning towards our customers.” Hans Wilden, who has run the family business together with his brother Bert, comments: “In Gerresheimer we have found a globally active and highly competitive partner with which the company will develop outstandingly well.”
Following the acquisition of Wilden, the Gerresheimer Group will in future comprise the four divisions of Tubular Glass, Moulded Glass, Life Science Research und Plastic Systems. The Group’s sales volume will grow to more than €900m. “Whether in North America, Europe or Asia we will in future have leading market positions in all the business sectors in which we are represented,” Herberg stresses. High technical entry barriers will in future secure this competitive position, he adds.
|
|
|
| |
|
|
